Home/Filings/4/A/0000905718-16-001262
4/A//SEC Filing

CHIASMA, INC 4/A

Accession 0000905718-16-001262

CIK 0001339469operating

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:15 PM ET

Size

16.9 KB

Accession

0000905718-16-001262

Insider Transaction Report

Form 4/AAmended
Period: 2015-07-15
Miles Vincent J
Director10% Owner
Transactions
  • Conversion

    Series D' Convertible Preferred Stock

    2015-07-151,642,5750 total(indirect: See Note)
    Common Stock (1,642,575 underlying)
  • Other

    Warrants (Right to Purchase)

    2015-07-15109,504109,504 total(indirect: See Note)
    Exp: 2024-12-16Common Stock (109,504 underlying)
  • Conversion

    Common Stock

    2015-07-15+2,080,5952,080,595 total(indirect: See Note)
  • Other

    Warrants (Right to Purchase)

    2015-07-15410,642410,642 total(indirect: See Note)
    Common Stock (410,642 underlying)
  • Conversion

    Series E Convertible Preferred Stock

    2015-07-15438,0200 total(indirect: See Note)
    Common Stock (438,020 underlying)
Footnotes (5)
  • [F1]Upon the closing of the Issuer's initial public offering, each share of Series D' Convertible Preferred Stock and Series E Convertible Stock automatically converted into Common Stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
  • [F2]Reflects a 1-for-9.132 reverse stock split effected on June 30, 2015.
  • [F3]The shares are held by Abingworth Bioventures V, LP ("Abingworth"). Abingworth Bioventures V GP LP ("Abingworth GP") serves as the general partner of Abingworth. Abingworth General Partner V LLP, serves as the general partner of Abingworth GP. Abingworth (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner V LLP) has delegated to Abingworth LLP, all investment and dispositive power over the securities held by Abingworth. The reporting person is a partner at Abingworth LLP and holds the reported securities indirectly through Abingworth. The reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person, Abingworth or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F4]Abingworth has the right to purchase shares of the Issuer's Common Stock under the Series D' Convertible Preferred Stock Purchase Agreement at a price of $0.09, which right to purchase is currently exercisable and expires with regards to half of the shares on March 28, 2022 and with regards to the other half of the shares on October 22, 2022.
  • [F5]Abingworth has the right to purchase shares of the Issuer's Common Stock under the Series E Convertible Preferred Stock Purchase Agreement at a price of $9.13, which right to purchase is currently exercisable and expires on December 16, 2024.

Issuer

CHIASMA, INC

CIK 0001339469

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001339469

Filing Metadata

Form type
4/A
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:15 PM ET
Size
16.9 KB